JILIN AODONG PHARMACEUTICAL GROUP CO., LTD. Funds and ETFs Jilin Aodong Pharmaceutical Group Co., Ltd.
Equities
000623
CNE000000719
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.89 CNY | -2.30% |
|
+1.36% | -1.65% |
| Apr. 17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
| Apr. 16 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ETFs positioned on Jilin Aodong Pharmaceutical Group Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 117 M€ | -0.10% | - | |
| 0.00% | 7 M€ | +1.36% | - | |
| 0.00% | 31 M€ | +2.75% | - | |
| 0.00% | 34 M€ | +1.51% | - |
Jilin Aodong Pharmaceutical Group Co., Ltd. specializes in the manufacturing and marketing of pharmaceutical products. Besides, the group offers food products. Net sales break down by activity as follows:
- sale of pharmaceutical products (89.4%);
- sale of food products (6.8%);
- other (3.8%).
All sales are in China.
Sector
Pharmaceuticals
Calendar
2024-05-17
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.89
CNY
Average target price
22.67
CNY
Spread / Average Target
+52.25%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.65% | 2.46B | |
| +34.00% | 704B | |
| +25.14% | 577B | |
| -7.75% | 348B | |
| +18.53% | 327B | |
| +4.95% | 288B | |
| +14.66% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.89% | 147B |
- Stock Market
- Equities
- 000623 Stock
- Funds and ETFs Jilin Aodong Pharmaceutical Group Co., Ltd.
